The present disclosure provides pharmaceutical compositions and methods for the treatment of a
sleep disorder such as
insomnia, by inducing, extending, or consolidating sleep. The compositions comprise
mirtazapine, or a salt or derivative thereof, optionally in combination with and
gabapentin, or a salt or derivative thereof, at relatively low doses of each such that the combination provides useful therapeutic benefit while avoiding unwanted side effects associated with treatment using alternative pharmaceutical agents.